MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review SR Volovat, C Volovat, I Hordila, DA Hordila, CC Mirestean, OT Miron, ... Frontiers in oncology 10, 526850, 2020 | 93 | 2020 |
Targeting CDK4/6 pathways and beyond in breast cancer D Ribnikar, SR Volovat, F Cardoso The Breast 43, 8-17, 2019 | 35 | 2019 |
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 1990-2022 Mensah, G, Fuster, V, Murray, C. et al. Global Burden of ... J Am Coll Cardiol 82 (25), 2350–2473, 2023 | 30 | 2023 |
Second-line chemotherapy with gemcitabine and oxaliplatin in combination with loco-regional hyperthermia (EHY-2000) in patients with refractory metastatic pancreatic cancer … C Volovat, SR Volovat, V Scripcaru, L Miron Rom Rep Phys 66 (1), 166-174, 2014 | 28 | 2014 |
Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania C Volovăt, I Cãruntu, C Costin, A Stefan, R Popa, S Volovăt, D Siriopol, ... BMC nephrology 14, 1-7, 2013 | 28 | 2013 |
Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin C Ureche, L Tapoi, S Volovat, L Voroneanu, M Kanbay, A Covic Journal of Human Hypertension 33 (6), 429-435, 2019 | 20 | 2019 |
Evaluation of cumulative effects of chemotherapy and bevacizumab (avastin) in oncological patients with periodontal disease D Nitescu, C Mihai, C Oanta Rev. Chim.(Bucharest) 68, 549, 2017 | 20 | 2017 |
Nephrotoxicity/renal failure after therapy with 90Yttrium-and 177Lutetium-radiolabeled somatostatin analogs in different types of neuroendocrine tumors: A systematic review CR Stolniceanu, I Nistor, SC Bilha, V Constantin, V Simona, M Matovic, ... Nuclear medicine communications 41 (7), 601-617, 2020 | 19 | 2020 |
The results of combination of ifosfamid and locoregional hyperthermia (EHY 2000) in patients with advanced abdominal soft-tissue sarcoma after relapse of first line chemotherapy SR Volovat, C Volovat, V Scripcaru, L Miron, C Lupascu Romanian Reports in Physics 66 (1), 175-181, 2014 | 18 | 2014 |
Landscape of immunotherapy options for colorectal cancer: current knowledge and future perspectives beyond immune checkpoint blockade A Gorzo, D Galos, SR Volovat, CV Lungulescu, C Burz, D Sur Life 12 (2), 229, 2022 | 17 | 2022 |
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer SR Volovat, TE Ciuleanu, P Koralewski, JEG Olson, A Croitoru, K Koynov, ... Oncotarget 11 (33), 3105, 2020 | 16 | 2020 |
The role of IgE specific for galactose-α-1, 3-galactose in predicting cetuximab induced hypersensitivity reaction: a systematic review and a diagnostic meta-analysis CV Lungulescu, BS Ungureanu, A Turcu-Stiolica, V Ghimpau, SA Artene, ... Scientific Reports 10 (1), 21355, 2020 | 11 | 2020 |
Oncogenic mechanisms in renal insufficiency SR Volovat, C Volovat, I Miron, M Kanbay, D Goldsmith, C Lungulescu, ... Clinical Kidney Journal 14 (2), 507-515, 2021 | 10 | 2021 |
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease … PCC GBD 2019 Lip, Oral JAMA Oncology 9 (10), 1321-1467, 2023 | 9* | 2023 |
The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis SR Volovat, C Volovat, SM Negru, M Danciu, V Scripcariu Journal of Chemotherapy 28 (3), 235-241, 2016 | 9 | 2016 |
Immunotherapy-Related Publications in Colorectal Cancer: A Bibliometric Analysis D Sur, C Lungulescu, II Puscariu, SR Volovat, M Preda, EA Mateianu, ... Healthcare 10 (1), 75, 2021 | 7 | 2021 |
Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients AC Carina Ureche, Gianina Dodi, Alexandra Covic, Alina Nedelcu, Simona R ... Journal of Clinical Medicine 12 (8), 2023 | 6 | 2023 |
Update on the use of nanocarriers and drug delivery systems and future directions in cervical cancer LM Himiniuc, BF Toma, R Popovici, AM Grigore, A Hamod, C Volovat, ... Journal of Immunology Research 2022, 2022 | 6 | 2022 |
Nanomedicine to modulate immunotherapy in cutaneous melanoma SR Volovat, S Negru, CR Stolniceanu, C Volovat, C Lungulescu, ... Experimental and Therapeutic Medicine 21 (5), 1-14, 2021 | 6 | 2021 |
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet, 2024 | 5 | 2024 |